Cyclic adenosine 3′,5′-monophosphate-binding proteins in human ovarian cancer: Correlations with clinicopathological features

Clinical Cancer Research

Volumn 2, Issue 1, 1996, Pages 201-206

  Simpson, Barbara J B ^a   Ramage, Anne D ^a,c   Hulme, Martin J ^a   Burns, David J ^a   Katsaros, Dionyssios ^b   Langdon, Simon P ^a   Miller, William R ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP BINDING PROTEIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL;

CARRIER PROTEINS; CYCLIC AMP RECEPTOR PROTEIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FEMALE; HUMANS; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; SURVIVAL RATE;

EID: 0030051727     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Walsh, D. A., Perkins, J. P., and Krebs, E. G. An adenosine 3′:5′-monophosphate dependent protein kinase from rabbit skeletal muscle. J. Biol. Chem., 243: 3763-3765, 1968.
2. Reimann, E. M., Walsh, D. A., and Krebs, E. G. Purification and properties of rabbit skeletal muscle adenosine 3′,5′-cyclic monophosphate-dependent protein kinases. J. Biol. Chem., 246: 1986-1995, 1971.
3. Miller, W. R., Elton, R. A., Dixon, J. M., Chetty, U., and Watson, D. M. A. Cyclic AMP binding proteins and prognosis in breast cancer. Br. J. Cancer, 61: 263-266, 1990.
4. Miller, W. R., Watson, D. M. A., Jack, W., Chetty, U., and Elton, R. A. Tumour cyclic AMP binding proteins: an independent prognostic factor for disease recurrence and survival in breast cancer. Breast Cancer Res. Treat., 26: 89-94, 1993.
5. Ramage, A. D., Burns, D. J., and Miller, W. R. Cyclic adenosine 3′,5′- monophosphate-binding proteins in human ovarian cancers. Br. J. Cancer, 69: 186-190, 1994.
6. Cho-Chung, Y. S. Differential therapy of cancer targeting the RIa regulatory subunit of cAMP-dependent protein kinase (Review). Int. J. Oncol., 3: 141-148, 1993.
7. Cho-Chung, Y. S., Clair, T., Tortora, G., and Yokozaki, H. Role of site-selective cAMP analogs in the control and reversal of malignancy. Pharmacol. & Ther., 50: 1-33, 1991.
8. Scully, S. R. Pathology of ovarian carcinoma. In: S. M. Piver, (ed.), Ovarian Malignancies, pp. 72-95. Edinburgh: Churchill Livingstone, 1987.
9. Scatchard, F. The attraction of proteins for small molecules and ions. Ann. N.Y. Acad. Sci., 51: 660-672, 1949.
10. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72: 248-254, 1976.
11. Pomerantz, A. H., Rudolph, S. A., Haley, B. E., and Greengard, P. Photoaffinity labelling of a protein kinase from bovine brain with 8-azidoadenosine 3′,5′ monophosphate. Biochemistry, 14: 3858-3862, 1975.
12. Ally, S., Tortora, G., Clair, T., Grieco, D., Merlo, G., Katsaros, D., Ogreid, D., Døskeland, S. O., Jahnsen, T., and Cho-Chung, Y. S. Selective modulation of protein kinase isozymes by the site-selective analog 8-chloroadenosine 3′,5′-cyclic monophosphate provides a biological means for control of human colon cancer cell growth. Proc. Natl. Acad. Sci. USA, 85: 6319-6322, 1988.
13. Yasui, W, Sumiyoshi, H., Ochiai, A., Yamahara, M., and Tahara, E. Type I and II cyclic adenosine 3′,5′- monophosphate-dependent protein kinase in human gastric mucosa and carcinomas. Cancer Res., 45: 1565-1568, 1985.
14. Fossberg, T. M., Doskeland, S. O., and Ueland, P. M. Protein kinases in human renal cell carcinoma and renal cortex. Arch. Biochem. Biophys., 189: 272-281, 1978.
15. Bradbury, A. W., Carter, D. C., Miller, W. R., Cho-Chung, Y. S., and Clair, T. Protein kinase-a (PK-A) regulatory subunit expression in colorectal-cancer and related mucosa. Br. J. Cancer, 69: 738-742, 1994.
16. Ansell, S. M., Rapoport, B. L. Falkson, G., Raats, J. I., and Moeken, C. M. Survival determinants in patients with advanced ovarian cancer. Gynecol. Oncol., 50: 215-220, 1993.
17. Taghaferri, P., Katsaros, D., Clair, T., Ally, S., Tortora, G., Neckers, L., Rubalcava, B., Parandoosh, Z., Chang, Y. A., Revankar, G. R., Crabtree, G. W., Robins, R. K., and Cho-Chung, Y. S. Synergistic inhibition of growth of breast and colon human cancer cell lines by site-selective cyclic AMP analogs. Cancer Res., 48: 1642-1650, 1988.
18. Tortora, G., Tagliaferri, P., Clair, T., Colaraonici, O., Neckers, L. M., Robins, R. K., and Cho-Cnung, Y. S. Site-selective cyclic AMP analogs at micromolar concentrations induce growth arrest and differentiation of acute promyelocytic, chronic myelocytic and acute lymphocytic human leukemia cell lines. Blood, 71: 230-233, 1988.
19. Parandoosh, Z., Rubalcava, B., Finch, R. A., Robins, R. K., and Avery, T. L. Changes in diacylglycerol and membrane associated protein kinase C activity reflect the growth status of xenografted human mammary carcinoma treated with 8-Cl-cAMP. Cancer Lett., 49: 195-200, 1990.
20. Ramage, A. D., Langdon, S. P., Ritchie, A. A., Burns, D. J., and Miller, W. R. Growth inhibition by 8-chloro cyclic AMP of human HT29 colorectal and ZR-75-1 breast carcinoma xenografts is associated with selective modulation of protein kinase A isoenzymes. Eur. J. Cancer, 31: 969-973, 1995.
21. Saunders, M. P., Salisbury, A. J., Harris, A. L., Long, L., O'Byrne, K. J., Macaulay, V. M., Mild, K., Cho-Chung, Y. S., and Talbot, D. C. Phase I study of the protein kinase A regulator 8-chloro cyclic AMP. Proc. Am. Assoc. Cancer Res., 36: 241, 1995.
22. Tortora, G., Ciardiello, F., Pepe, S., Tagliaferri, P., Ruggiero, A., Bianco, C., Guarrasi, K., and Bianco, A. R. Phase I clinical study with 8-chloro-cAMP and evaluation of immunological effects in cancer patients. Clin. Cancer Res, 1: 377-384, 1995.
23. Yokozaki, H., Budillon, A., Tortora, G., Meissner, S., Beaucage, S. L., Miki, K., and Cho-Chung, Y. S. An antisense oligodeoxynucleotide that depletes RIα subunit of cyclic AMP-dependent protein kinase induces growth inhibition in human cancer cells. Cancer Res., 53: 868-872, 1993.
24. Clair, T., Yokozaki, H., Tortora, G., Meissner, S., Beucage, S. L., and Cho-Chung, Y. S. An antisense oligodeoxynucleotide targeted against the type I regulatory subunit (RIα) mRNA of cAMP-dependent protein kinase A (PKA) inhibits the growth of LS-174T human colon carcinoma in athymic mice. Proc. Am. Assoc. Cancer Res., 32, 277, 1991.